Invivyd (IVVD) Common Equity (2020 - 2026)
Invivyd's Common Equity came in at $181.08 million for Q2 2026, up 323.2% from $42.79 million a year earlier.
Powered by 
Analysis
Invivyd (IVVD) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Invivyd's Common Equity was $241.54 million, up 257.6% from FY2024.
- Going back by year, Common Equity was $67.54 million in FY2024 (-61.9%), $177.47 million in FY2023 (-50.1%), $355.97 million in FY2022 (-36.2%) and $558.02 million in FY2021.
- The five-year range for quarterly Common Equity is $42.79 million (Q2 2025) to $633.21 million (Q3 2021).
- Year-over-year, Common Equity increased in three of the last seven quarters, with growth averaging 46.5%.
- The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 323.2%), and the weakest in Q1 2025 (a decline of 69.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Invivyd | 206.42 Mn | -300.22 Mn | 13.01 Mn | 181.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 181.08 Mn |
| Dec 31, 2025 | 241.54 Mn |
| Sep 30, 2025 | 93.07 Mn |
| Jun 30, 2025 | 42.79 Mn |
| Mar 31, 2025 | 54.15 Mn |
| Dec 31, 2024 | 67.54 Mn |
| Sep 30, 2024 | 83.16 Mn |
| Jun 30, 2024 | 140.64 Mn |
| Mar 31, 2024 | 178.50 Mn |
| Dec 31, 2023 | 177.47 Mn |
| Sep 30, 2023 | 246.50 Mn |
| Jun 30, 2023 | 281.56 Mn |
| Mar 31, 2023 | 326.75 Mn |
| Dec 31, 2022 | 355.97 Mn |
| Sep 30, 2022 | 377.44 Mn |
| Jun 30, 2022 | 414.84 Mn |
| Mar 31, 2022 | 459.39 Mn |
| Dec 31, 2021 | 558.02 Mn |
| Sep 30, 2021 | 633.21 Mn |
| Jun 30, 2021 | -144.62 Mn |
API Access
Invivyd Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IVVD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();